| 1.0 |
3.1 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) |
| 0.9 |
2.7 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.8 |
7.3 |
GO:0033602 |
negative regulation of dopamine secretion(GO:0033602) |
| 0.7 |
2.1 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 0.6 |
2.3 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.6 |
2.3 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.5 |
1.6 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
| 0.5 |
2.3 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) |
| 0.4 |
1.3 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.4 |
4.0 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.4 |
1.1 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.3 |
1.7 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.3 |
1.3 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.3 |
1.9 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.3 |
1.8 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.3 |
2.7 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.3 |
0.9 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.3 |
1.4 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.3 |
1.1 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.3 |
2.9 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.3 |
0.8 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.3 |
1.0 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.2 |
2.5 |
GO:0006691 |
leukotriene metabolic process(GO:0006691) |
| 0.2 |
2.4 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.2 |
1.0 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.2 |
0.7 |
GO:0032240 |
RNA import into nucleus(GO:0006404) mRNA export from nucleus in response to heat stress(GO:0031990) negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.2 |
2.3 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.2 |
0.2 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 |
0.7 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.2 |
1.1 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.2 |
0.9 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.2 |
0.4 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.2 |
1.3 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.2 |
1.0 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.2 |
0.8 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) |
| 0.2 |
1.5 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.2 |
1.6 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 |
2.5 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.2 |
2.8 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.2 |
0.8 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.2 |
0.8 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.2 |
1.4 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.2 |
1.0 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.2 |
0.6 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.2 |
1.0 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.2 |
1.8 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.2 |
0.9 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.2 |
0.9 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.2 |
0.5 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.2 |
1.4 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.2 |
0.3 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.2 |
1.3 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.2 |
1.3 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.2 |
1.1 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 |
0.8 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.2 |
0.5 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.2 |
1.4 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.2 |
0.9 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 |
1.1 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.1 |
0.7 |
GO:2000065 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.1 |
1.8 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
1.0 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.1 |
1.1 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.1 |
2.3 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.1 |
0.4 |
GO:1904569 |
regulation of selenocysteine incorporation(GO:1904569) |
| 0.1 |
3.6 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 |
0.6 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.1 |
4.3 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 |
1.2 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.1 |
1.6 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 |
0.4 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.1 |
1.3 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 |
0.4 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.1 |
0.5 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 |
0.4 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 |
1.7 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.1 |
1.3 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.1 |
0.3 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.1 |
0.8 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
0.5 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.1 |
0.3 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.1 |
1.3 |
GO:0015697 |
quaternary ammonium group transport(GO:0015697) |
| 0.1 |
0.4 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.1 |
1.0 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.9 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
1.0 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.1 |
0.5 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.1 |
0.5 |
GO:0031133 |
cellular magnesium ion homeostasis(GO:0010961) regulation of axon diameter(GO:0031133) |
| 0.1 |
2.9 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 |
0.7 |
GO:1902805 |
positive regulation of synaptic vesicle transport(GO:1902805) |
| 0.1 |
0.3 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 |
2.8 |
GO:0001964 |
startle response(GO:0001964) |
| 0.1 |
0.6 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.1 |
0.2 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.1 |
0.4 |
GO:0098915 |
membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.1 |
0.4 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.1 |
0.4 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.1 |
0.2 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 0.1 |
2.8 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.1 |
5.1 |
GO:0015807 |
L-amino acid transport(GO:0015807) |
| 0.1 |
0.4 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 |
1.5 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.1 |
0.5 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.1 |
1.4 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.1 |
0.5 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.1 |
0.8 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.1 |
0.4 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 |
1.3 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 |
1.1 |
GO:0051383 |
kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
| 0.1 |
1.1 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 |
0.5 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
0.5 |
GO:0060527 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.1 |
0.3 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 |
0.6 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.4 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.2 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.1 |
2.3 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.2 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.1 |
0.4 |
GO:0043084 |
penile erection(GO:0043084) |
| 0.1 |
1.2 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
0.8 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.1 |
0.6 |
GO:2000821 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) regulation of grooming behavior(GO:2000821) |
| 0.1 |
0.4 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 |
0.5 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.1 |
0.2 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 |
2.4 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.1 |
0.4 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.1 |
GO:0072393 |
microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.1 |
0.4 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.0 |
0.4 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.0 |
1.2 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
0.2 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.0 |
0.4 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.0 |
3.8 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.0 |
2.6 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.3 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 |
0.1 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.0 |
0.2 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.0 |
0.3 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.0 |
0.2 |
GO:0071639 |
respiratory burst involved in defense response(GO:0002679) positive regulation of monocyte chemotactic protein-1 production(GO:0071639) chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) positive regulation of interleukin-6 secretion(GO:2000778) |
| 0.0 |
0.6 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.1 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.0 |
0.9 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.0 |
0.2 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.0 |
0.5 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 |
1.8 |
GO:1902668 |
negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
| 0.0 |
0.5 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.4 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
2.6 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
1.0 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.0 |
0.3 |
GO:0042996 |
regulation of Golgi to plasma membrane protein transport(GO:0042996) |
| 0.0 |
0.3 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 |
0.5 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.0 |
0.5 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.3 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.5 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.0 |
0.7 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.0 |
1.1 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 |
0.7 |
GO:0001990 |
regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.0 |
1.0 |
GO:0090102 |
cochlea development(GO:0090102) |
| 0.0 |
0.6 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 |
0.4 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.0 |
0.4 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
2.0 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.0 |
0.5 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.0 |
0.2 |
GO:0071941 |
nitrate metabolic process(GO:0042126) nitrogen cycle metabolic process(GO:0071941) |
| 0.0 |
0.1 |
GO:0035793 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) cell migration involved in kidney development(GO:0035787) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 0.0 |
0.5 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.0 |
0.6 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 |
0.0 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.0 |
0.1 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.0 |
0.6 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.0 |
0.1 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.0 |
1.0 |
GO:0010324 |
membrane invagination(GO:0010324) |
| 0.0 |
0.7 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.0 |
0.5 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.0 |
0.9 |
GO:1900046 |
regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.0 |
0.3 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
0.1 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.0 |
0.0 |
GO:1900225 |
NLRP3 inflammasome complex assembly(GO:0044546) regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
| 0.0 |
0.4 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.0 |
0.4 |
GO:0000281 |
mitotic cytokinesis(GO:0000281) |
| 0.0 |
0.2 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.0 |
0.7 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 0.0 |
0.1 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.3 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.0 |
0.2 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.0 |
0.1 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.0 |
GO:0071404 |
calcium-independent cell-matrix adhesion(GO:0007161) cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
| 0.0 |
0.3 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.5 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
